These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16794601)

  • 1. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs.
    Verhagen AM; Kratina TK; Hawkins CJ; Silke J; Ekert PG; Vaux DL
    Cell Death Differ; 2007 Feb; 14(2):348-57. PubMed ID: 16794601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the sequence specificity of XIAP BIR domains by screening a combinatorial peptide library.
    Sweeney MC; Wang X; Park J; Liu Y; Pei D
    Biochemistry; 2006 Dec; 45(49):14740-8. PubMed ID: 17144666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis.
    Srinivasula SM; Hegde R; Saleh A; Datta P; Shiozaki E; Chai J; Lee RA; Robbins PD; Fernandes-Alnemri T; Shi Y; Alnemri ES
    Nature; 2001 Mar; 410(6824):112-6. PubMed ID: 11242052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
    Liu Z; Sun C; Olejniczak ET; Meadows RP; Betz SF; Oost T; Herrmann J; Wu JC; Fesik SW
    Nature; 2000 Dec 21-28; 408(6815):1004-8. PubMed ID: 11140637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
    Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
    Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP.
    Sun C; Cai M; Gunasekera AH; Meadows RP; Wang H; Chen J; Zhang H; Wu W; Xu N; Ng SC; Fesik SW
    Nature; 1999 Oct; 401(6755):818-22. PubMed ID: 10548111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
    Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
    Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP.
    Silke J; Ekert PG; Day CL; Hawkins CJ; Baca M; Chew J; Pakusch M; Verhagen AM; Vaux DL
    EMBO J; 2001 Jun; 20(12):3114-23. PubMed ID: 11406588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
    Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
    J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
    Huang Y; Park YC; Rich RL; Segal D; Myszka DG; Wu H
    Cell; 2001 Mar; 104(5):781-90. PubMed ID: 11257231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of peptide-binding specificity of IAP BIR domains.
    Eckelman BP; Drag M; Snipas SJ; Salvesen GS
    Cell Death Differ; 2008 May; 15(5):920-8. PubMed ID: 18239672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation.
    Sasaki Y; Minamizawa M; Ambo A; Sugawara S; Ogawa Y; Nitta K
    FEBS J; 2008 Dec; 275(23):6011-21. PubMed ID: 19016849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity.
    van Loo G; van Gurp M; Depuydt B; Srinivasula SM; Rodriguez I; Alnemri ES; Gevaert K; Vandekerckhove J; Declercq W; Vandenabeele P
    Cell Death Differ; 2002 Jan; 9(1):20-6. PubMed ID: 11803371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
    Abhari BA; Davoodi J
    J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
    Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW
    J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins.
    Verhagen AM; Silke J; Ekert PG; Pakusch M; Kaufmann H; Connolly LM; Day CL; Tikoo A; Burke R; Wrobel C; Moritz RL; Simpson RJ; Vaux DL
    J Biol Chem; 2002 Jan; 277(1):445-54. PubMed ID: 11604410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.
    Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Tomita Y; Krajewski K; Roller PP; Wang S
    J Med Chem; 2004 Aug; 47(17):4147-50. PubMed ID: 15293984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.